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Purpose: Although patency data for lower extremity b pass grafts are readily available, few 
reports have focused on patients' atisfaction after surgical reconstruction for claudication. 
We reviewed our experience with surgical treatment for claudication, focusing on late 
outcome from the patients' perspective to further refine surgical decision making in 
patients with intermittent claudication. 
Patients and Methods: From February 1987 through April 1994, 114 consecutive patients 
underwent surgical bypass for intermittent claudication. Nine patients were lost o 
follow-up, leaving the study cohort composed of 105 patients with a mean age of 63 years 
(range 42 to 82 years). Sixty-two percent of the procedures were inflow reconstructions, 
and the remainder were infrainguinal bypasses. Clinical and demographic data were 
gathered from record review, and late follow-up was obtained by return visit or telephone 
interview. Patient satisfaction and level of function were assessed by a simple five-point 
questionnaire administered by a research nurse. Actuarial methods were used to calculate 
late graft patency and survival. Cox regression analysis was used to identify clinical and 
anatomic factors predictive of late survival nd favorable outcome. 
Results: Cardiac risk assessment revealed that 75% of patients either had no clinical markers 
for cardiac disease or had been treated with previous coronary artery bypass grafting or 
percutaneous transluminal a gioplasty; despite this 61% of patients underwent specific 
preoperative cardiac testing. Most (68%) inflow procedures were aortobifemoral bypass 
grafts, and 93% of outflow procedures were femoropopliteal bypass grafts. Two thirds of 
infrainguinal grafts were performed with autogenous conduits, with prosthetic femo- 
ropopliteal bypass grafts performed only to the above-knee popliteal artery. Early graft 
failure with successful immediate revision occurred in 5% of patients. No operative deaths 
or early or late amputations occurred. At a mean follow-up of 4.5 years 96% of surviving 
patients had a patent graft. However, primary unassisted patency at 4 years was superior 
for inflow (92% + 4%) versus outflow (81% + 6%) procedures ( p = 0.009). Late readmis- 
sion for cardiac-related vents occurred in 12%, and late cardiac-related death occurred in 
5%. Actuarial survival at 5 years was 80% + 5%, with diabetes being the only negative 
survival predictor (risk ratio 2.6, 95% confidence interval 1 to 7, p = 0.049); 60% of late 
deaths were cancer-related. Satisfactory late results were reported by 82% of patients, with 
age <70 years (odds ratio 4.01, 95% confidence interval 1.2 to 13.7, p = 0.026) and 
normalization ( >0.85) of ankle/brachial index (odds ratio 5.7, 95% confidence interval 1.6 
to 20, p = 0.008) being powerful independent predictors of patient satisfaction. 
Conclusions: After considering cardiac-related short- and long-term prognosis, we con- 
elude that lower extremity bypass grafting for intermittent claudication will produce 
optimal results when restricted to younger (<70 years) nondiabetic patients in whom near 
normalization of the postoperative ankle/brachial index can be anticipated. (J Vasc Surg 
1996;24:65-73.) 
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There is general consensus that intermittent clau- 
dication is at most a relative indication for vascular 
reconstruction. This posture is related to the rela- 
tively benign natural history 1 (with respect o limb 
loss) and longevity limitations imposed by the fre- 
quently associated cardiac disease in patients with 
intermittent claudication. The Framingham Study 
previously documented intermittent claudication as 
65 
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a strong marker for subsequent morbid coronary 
events} In addition, both surgical and catheter- 
based interventions carry potential short- and long- 
term morbidity. Finally, conservative management 
with risk factor control, 3exercise training, 4 or medi- 
cal therapy s will relieve or at least improve claudi- 
cation in some patients. 
The percentage of surgical revascularization car- 
ried out for intermittent claudication will vary as a 
function of patient demographics, urgical results, 
and prevailing attitudes inany particular institution. It
is clear that operation for claudication constitutes a 
significant portion of procedures in modern clinical 
series of surgical bypass for peripheral occlusive dis- 
ease. Kent et al.6 reported that 21% of procedures in 
a 10-year experience with femoropopliteal bypass 
graft were performed for claudication. In a previous 
report from our institution Brewster and Darling 7 
noted that during two separate time intervals, inter- 
mittent claudication was the indication for aortoiliac 
reconstruction i  65% and 48% of cases, respectively. 
In addition, both from the standpoint of bypass graft 
patency 8,9 and long-term prognosis, mpatients treated 
for intermittent claudication fare considerably better 
than those with limb-threatening ischemia. Finally, 
current clinical series document hat a significant 
percentage (range 7% to 29% at a mean follow-up 
of 5 years) of patients who have claudication will 
progress to limb-threatening status and thereby re- 
quire intervention and that the overall morbidity of 
surgical treatment for claudication is acceptably 
low. L6,8,l°a4 Although intervention for intermittent 
claudication is a matter of surgical judgment, it is clear 
that such interventions (whether surgical or catheter- 
based) are justified only if they are safe, effective, and 
durable and if they are performed after the long-term 
prognosis for both life and limb is considered. 
Although patency data for lower extremity revas- 
cularization are readily available, few reports have 
focused on patient satisfaction after surgical treatment 
for intermittent claudication. To refine decision mak- 
ing in patients with intermittent claudication, we 
report a series of 105 patients treated with operation, 
emphasizing patient satisfaction and late outcome 
with respect o both the vascular reconstruction a d 
late survival. 
PATIENTS AND METHODS 
From February 1987 through April 1994 (se- 
lected to ensure a minimum 1-year follow-up) 114 
consecutive patients in a single surgical practice 
(R. P. C. ) were treated with operation for intermittent 
claudication. Nine patients were lost to follow~up and 
were not further considered, leaving 105 patients 
forming the study cohort. These 114 patients repre- 
sented 25% of 460 patients undergoing inflow and 
infrainguinal bypass grafts performed for peripheral 
occlusive disease during the study interval. The mean 
age was 63 + 9 years (range 42 to 82 years). Patients 
with rest pain, ulceration, or gangrene were excluded. 
In general, surgical intervention was undertaken only 
after sufficient ime had elapsed for stabilization of 
symptoms and collateral circulation recruitment. 
Claudication had been present for a mean duration of 
34.6. + 26 months (range 2 to 120 months). Demo- 
graphic and clinical characteristics are displayed in 
Tables I and II. Patients were considered iabetic if 
they required iet modification, oral hypoglycemics, 
or insulin for blood glucose control. As displayed in 
Table II, 75% of patients had either a negative cardiac 
risk profile (46%) as defined by published and vali- 
dated clinical markers of cardiac disease is or had 
undergone coronary artery bypass grafting (CABG) 
or percutaneous transluminal coronary angioplasty 
(29%). Despite these data 61% of patients underwent 
specific preoperative cardiac testing, most with dipy- 
ridamole-thallium scintigraphy because of the relative 
indications for operation. After the operation, pa- 
tients were examined at 2-, 6-, and 12-month inter- 
vals during the first year and annually thereafter. 
Noninvasive studies (segmental pressures and pulse 
volume recordings) were performed at each evalua- 
tion, and grafts were considered failed when the 
criteria of the Ad Hoc Committee on Reporting 
Standards to assess patency were not met} 6 Grafts 
were considered failing if they exhibited signs of 
hemodynamic deterioration but with duplex imaging 
were found to be anatomically patent. Improvement 
in postoperative ankle brachial index (ABI) was de- 
fined as an increase in ABI of_>0.2 (greater than the 
0.i threshold increase recommended bythe Ad Hoc 
Committee, because all patients had claudication) 
compared with preoperative study on either the 
resting or postexercise tudy. Normalization was de- 
fined as a postoperative ABI _>0.85 on either the 
resting or postexercise tudy. 
Primary patency and secondary patency were 
defined in accordance with the Ad Hoc Committee 
on Reporting Standards. 16Late graft patency and 
survival were determined by actuarial life table analy- 
sis. A statistics package (BMDPll, BMDP, Inc, Los 
Angeles, Calif.) was used to perform the life table 
analysis. Stepwise Cox regression analysis (BMDP2L) 
was used to determine independent factors associated 
with either survival or primary patency. 
To determine survival and quality of life after 
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operation, patients were evaluated during return 
office visit (75%), contacted by letter (15%), or 
interviewed by telephone (10%). Patient satisfaction 
was assessed through a five-point questionnaire (see 
Appendix I) administered by a research nurse. Patient 
satisfaction was defined as a positive answer to at least 
four of the five questions. Ninety-four percent of 
those with positive responses to four of five questions 
also answered five of five questions with positive 
responses. Satisfaction data were collected on 97 
patients; this number includes 10 deceased patients in 
whom adequate follow-up information (mean fol- 
low-up duration 41 months) with respect o graft 
patency was available (in the form of noninvasive 
studies), and a surviving spouse answered the ques- 
tionnaire. Factors associated with patient satisfaction 
were compared by Z 2 analysis or Fisher's exact test 
(BMDP4F) where appropriate. Stepwise multivariate 
logistic regression analysis (BMDPLR) was used to 
identify the independent predictors of patient saris- 
faction. 
RESULTS 
Follow-up evaluation was completed for a mean 
period of 54 months (range 12 to 96 months). 
Eighty-six percent of the patients underwent a pri- 
mary operation, whereas the remainder had under- 
gone previous operation for intermittent claudication 
by a different surgeon. Mean preoperative ABI and 
early postoperative and late follow-up indexes are 
displayed on Table III. Surgical procedures were 
performed as detailed in Fig. 1. Prosthetic femo- 
ropopliteal bypass grafts were performed only to the 
above-knee popliteal artery. Twenty-two (55%) of the 
femoropopliteal bypass grafts were at the above-knee 
level, and 18 (45%) were below-knee; three femoral- 
tibial reconstructions were done. Early graft failure 
with successful immediate revision occurred in five 
patients; all patients were discharged with a patent 
graft. No deaths occurred within 30 days after the 
operation. Early postoperative complications oc- 
curred in seven patients and included myocardial 
infarction (n = 1), pulmonary edema (n = 1), pneu- 
monia (n = 1), postoperative transient ischemic attack 
(n = 1), deep venous thrombosis (n = 1), and mild 
postoperative r nal insufficiency (n = 2). 
No early or late amputations occurred. Late graft 
failure occurred in 12 patients (7 with outflow and 5 
with inflow procedures). Nine of the 12 failed grafts 
underwent reoperation, and seven of nine remained 
patent at last follow-up. Failing grafts were detected in 
four patients; all were successfully revised. 
Primary and secondary graft patencies are illus- 
Table I. Demographic haracteristics in 105 
surgically treated patients with claudication 
No. Percent 
Male 70 67 
Female 35 33 
Diabetes 18 17 
Smoking 
None 16 15 
Current 57 54 
Past 32 31 
Hypertension 58 55 
Mean age was 63 years (42 to 82 years). 
trated in Fig. 2, and the corresponding life tables are 
displayed in Tables IV and V. Primary unassisted 
patency at 4 years was superior for inflow (92% + 4%) 
versus outflow (81% + 6%) procedures (p = 0.009). 
Secondary patency was 96% + 3% for both inflow and 
outflow procedures. At late follow-up 96% of patients 
had a patent reconstruction. 
Cumulative survival at 5 years was 80% + 5%, not 
significantly different from that expected for a normal 
age-matched cohort (Fig. 3). Diabetes was the only 
independent negative predictor of late survival (risk 
ratio 2.6, 95% confidence interval 1 to 7, p -- 0.049). 
Of  the 18 deaths, 4 (22%) were caused by myocardial 
infarction, 9 were cancer-related, 1 was caused by a 
stroke, i was caused by renal failure, and 3 were from 
unknown causes. Twelve (11%) patients had late 
hospitalization because of cardiac morbidity that 
included angina (n=3) ,  myocardial infarction 
(n = 3), CABG (n = 5), and percutaneous translumi- 
nal angioplasty (n = 1). 
Satisfactory late results were reported by 82% of 
patients in whom satisfaction data were collected 
(n = 97). Univariate analysis (Table VI) indicated that 
age _<70 years (p  < 0.001), normalization of ABI 
( p -- 0.002), previous CABG ( p = 0.030), and in- 
flow procedures ( p = 0.05 ) were positively associated 
with patient satisfaction. Corroborating the latter 
factor was the fact that negative responses (10 of 17) 
tended to cluster among patients who had undergone 
outflow procedures (p= 0.05). Eight patients re- 
ported a satisfactory result despite late graft failure. 
Six of those eight patients underwent successful graft 
revision with a patent graft at the time of question- 
naire completion. The remaining two patients had a 
patent graft for 72 and 73 months, respectively, and 
were sufficiently stable at the time of late graft failure 
that no further therapy was recommended. Multivari- 
ate analysis confirmed that age younger than 70 years 
and normalization of ABI were significant indepen- 
dent predictors of satisfaction: that is, patients 
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105 PATIENTS 
114 PROCEDURES 
INFLOW PROCEDURES n--71 (62%) 
# % 
AORTOBIFEMORAL BG 48 68% 
FEM-FEM 10 14% 
ILIO-FEM 4 6% 
AXILLO-B FEM 1 1% 
PROFUNDAPLASTY 5 7% 
COMMON FEM END. 2 3% 
AORTOILIAC END. 1 1% 
OUTFLOW PROCEDURES n--43 (38%) 
FEMORAL POPLITEAL BG n---40 (93%) 
Above Knee Below Knee 
22 (55%) 18 (45°/0) 
vein prosth, vein prosth. 
8(36%) 14(64°/0) 18(100%) 0 
FEMORAL TIBIAL BG n=3 (7%) 
vein prosth. 
3 (100%) 0 
Hg.  1. Surgical procedures performed in 105 patients with claudication. Total number of  
procedures reflects bilateral femoral-popliteal bypass graft in four patients and combined 
inf low/outf low procedures in five patients. 
Table II. Coronary artery disease status in 105 patients 
No. Percent 
Negative clinical profile* 48 46 
S/P CABG or PTCA 30 29 
Previous MI or angina 27 25 
*As defined by absence of markers of occult coronary artery disease (age >70 years, diabetes, history of myocardial infarction, history of 
angina or ventricular ectopy), and/or major markers of coronary artery disease (recent or poorly controlled chronic heart failure, recent 
myocardial infarction, unstable or recent onset of angina). 
PTCA, Percutaneous transluminal coronary angioplasty; MI, myocardial infarction; CABG, coronary artery bypass graft. 
Table I I I .  Mean ankle/brachial index in 105 surgically treated patients with claudication 
Preoperative versus Postoperative rsus 
Preoperative Postoperative Late follow-up postoperative late 
Resting ABI 0.59 + 23 0.84 + 22 0.80 + 24 0.001 NS 
Postexercise ABI 0.28 + 30 0.76 _+ 32 0.68 + 32 0.001 NS 
NS, Not significant. 
younger than 70 years of age were four times more 
likely to report satisfactory results compared with 
patients older than 70 years of age (odds ratio = 4.01, 
95% confidence interval 1.2 to 13.7; p= 0.026). 
Similarly, patients whose ABIs normalized were nearly 
six times more likely to report a satisfactory esult han 
were those whose did not (odds ratio = 5.7, 95% 
confidence interval 1.6 to 20; p = 0.008). 
D ISCUSSION 
The rationale for a conservative approach to most 
patients with intermittent claudication relates both to 
its benign prognosis with respect to threat of limb loss 
and to the limitations on longevity imposed princi- 
pally by concomitant cardiac disease. Sufficient natu- 
ral history data are available documenting a modest 
(range 5 % to 8%) late amputation rate for patients who 
have claudication, ~ and most clinicians agree that 
disease progression to limb-threatening ischemia can 
be dealt with when and if it occurs. In fact, the 
subsequent requirement for intervention is not un- 
usual, occurring in 13% to 29% of patients in reports 
that have examined this factor./'n'13'14 The impor- 
tance of the initial ABI in predicting acceleration to 
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Fig. 2. A, Long-term primary unassisted patency for inflow (•) and outflow (0) procedures. 
Numbers of grafts at risk for different intervals are shown. B, Long-term primary and secondary 
patency for inflow and outflow procedures. • = primary, inflow; • = primary, outflow; 0 = sec- 
ondary, inflow; ~ -- secondary, outflow. 
more severe clinical grades has been well docu- 
mented. H,13,~4,17 In a previous report from our unit 
we found that 29% of 51 patients with claudication 
who had a resting ABI <0.5 required subsequent 
intervention for resting ischemia t a mean follow-up 
of 23 months./3 Although the threat of disease 
progression and limb loss is often paramount from the 
patient's perspective, clinical decision making with 
respect to intervention i patients with clandication is 
primarily influenced by the short- and long-term 
sequelae of the frequently associated cardiac disease 
and by those factors of vascular anatomy that will 
influence the safety, efficacy, and durability of the 
proposed intervention. 
There is general consensus that the presence of 
lower extremity occlusive disease is an important 
marker for associated coronary artery disease. Most 
reports note that approximately 50% of late deaths in 
these patients are related to cardiac causes. 1°,18 Mul- 
tiple reports that detail ate survival in patients with 
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Fig. 3. Long-term survival of current study cohort (n) 
compared with survival of normal age-matched population 
(-). 
peripheral vascular disease document actuarial 5-year 
survival rates in the 50% range (range 45% to 
85%). ~4'~9-2° However, with respect o decision mak- 
ing in patients with claudication, it is clear that these 
patients fare significantly better when compared with 
patients with more critical ischemia. 12,~8 The 80% 
survival at 5 years in our patients is remarkably 
consistent with other reports 1°,~4 in which patients 
with intermittent claudication have been segregated 
from those with more critical ischemia. Similar to our 
data (Fig. 3), the large and carefully conducted study 
of Dawson et al. 1° verified that late survival in patients 
with claudication who were treated with operation 
equaled that of an age-matched general population. 
These authors also noted, as we have previously 
reported, 2~ that readily apparent clinical markers of 
coronary disease can both predict late cardiac events 
and select patients for more comprehensive cardiac 
testing. We agree with Hertzer 18 that such testing is an 
important strategy in selecting patients for interven- 
tion and improving long-term prognosis by detecting 
those patients whose coronary artery disease would 
on its own merits require mechanical intervention. 
Our series reflects an aggressive posture towards 
short- and long-term cardiac risk stratification in 
patients with claudication being evaluated for inter- 
vention. Seventy-five percent of our patients had 
either a negative cardiac risk profile as defined by 
Eagle et al) 5 or had undergone CABG or percutane- 
ous transluminal coronary angioplasty. Despite this, 
our low threshold for preoperative cardiac testing in 
patients with claudication is evident in that 60% of the 
patients in this series underwent such testing, afigure 
twice that reported from our unit before abdominal 
aortic operation was pcrformed. 22 This difference, of 
course, relates to the indication for the intervention. 
Despite our preference for a selective approach to 
preoperative cardiac testing based on clinical profil- 
ing, 15'21'22 we believe a low threshold for such testing 
is appropriate when lifestyle-modifying as opposed to 
life- or limb-saving interventions are contemplated. 
The encouraging results with respect to early postop- 
erative cardiac omplications (0.9%), late rehospital- 
ization for cardiac events (11%), and late cardiac death 
(4%) reflect he stringent patient selection for inter- 
vention that is often based on objective preoperative 
cardiac testing: These figures compare favorably with 
that reported by Dawson et al.,10 who noted late 
cardiac events in 34% of patients at 5 years after lower 
extremity bypass grafting. Indeed, our own recently 
reported data documented a 40% rate of fatal and 
nonfatal myocardial infarction (i.e., exclusive of less 
serious cardiac events) at 5 years in 171 patients who 
underwent infrainguinal revascularization for both 
claudication and limb-threatening ischemia. 21 Clearly 
our series represents patients selected for minimal 
short- and long-term cardiac risk, and such selection 
would appear appropriate in patients being consid- 
ered for surgical treatment of claudication. 
The efficacy and durability of symptom relief after 
treatment for claudication will be determined largely 
by individual patients' vascular anatomy. Maintenance 
of a patent graft is crucial in this regard, and we agree 
with Bandyk et al. 23 that a surveillance protocol is 
useful in improving overall graft performance. In our 
series 96% of patients at last follow-up had a patent 
reconstruction. As expected, primary unassisted pa- 
tency at 4 years for inflow procedures (92%) was 
superior to that for outflow operations (81%), and 
these patency rates, both in the inflow and outflow 
groups, are similar to those of other series. 8,24 Our 
11.5% rate of secondary interventions to maintain or 
restore graft patency is similar to that of other 
contemporary eports. 2s This significant rate of sec- 
ondary interventions occurred despite the fact that 
these patients had favorable anatomy for reconstruc- 
tion, because patients who might require "disadvan- 
taged" reconstructions (poor outflow, inadequate 
conduits) are generally not offered reconstruction for 
claudication alone. For example, there were but three 
tibial-level reconstructions in this series, although 
Conte et al.8 have recently reported favorable results 
with tibial level grafting in carefully selected patients 
with claudication. The requirement for reinterven- 
tion per se did not adversely affect he patients' per- 
ception of achieving a satisfactory esult (Table VI). 
Few reports in the surgical literature have consid- 
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Table IV. Life table analysis of primary unassisted graft patency 
Interval No. at No. lost to Interval patency Cumulative Standard error 
(too) risk No. withdrawn follow-up No.failed (%) patency (%) (%) 
Inflow 
0-6 64 5 0 1 98.4 100.0 0.0 
6-12 58 0 0 2 96.6 98.4 1.6 
12-18 56 9 0 0 100.0 95.0 2.8 
18-24 47 4 0 0 100.0 95.0 2.8 
24-30 43 3 0 0 100.0 95.0 2.8 
30-36 40 6 0 0 100.0 95.0 2.8 
36-42 34 1 0 1 97.0 95.0 2.8 
42-48 32 3 0 0 0.0 92.2 3.9 
48-54 29 4 0 0 0.0 92.2 3.9 
54-60 25 4 0 0 0.0 92.2 3.9 
60-66 21 4 0 1 94.7 92.2 3.9 
66-72 16 6 0 0 100.0 87.3 6.0 
72-78 10 2 0 0 100.0 87.3 6.0 
Outflow 
0-6 40 3 0 5 87.0 100.0 0.0 
6-12 32 4 0 2 93.3 87.0 5.4 
12-18 26 4 0 0 100.0 81.2 6.4 
18-24 22 3 0 0 100.0 81.2 6.4 
24-30 19 1 0 0 100.0 81.2 6.4 
30-36 18 3 0 0 100.0 81.2 6.4 
36-42 15 3 0 0 100.0 81.2 6.4 
42-48 12 1 0 0 100.0 81.2 6.4 
48-54 11 2 0 1 90.0 81.2 6.4 
54-60 8 0 0 0 100.0 73.1 9.6 
60-66 8 1 0 0 100.0 73.1 9.6 
66-72 7 1 0 0 100.0 73.1 9.6 
72-78 6 2 0 0 60.0 73.1 9.6 
ered the patients' perception of symptom relief and 
functional status after revascularization. 8'2628 We 
agree with Hiatt et al. 29 that validated quantitative 
methods to assess both hemodynamic and functional 
limitations and the application of these before and 
after treatment represent the optimal circumstance 
for assessing the worth of interventions for clandica- 
tion. We aclmowledge the constraints of retrospective 
review and the use of a simple nonvalidated question- 
naire as limitations of this report. However, Albers et 
al. 28 demonstrated good correlation in the responses 
to a detailed, validated, quality-of-life questionnaire 
and a simple derivative questionnaire. Furthermore, 
the significant functional limitations imposed by 
limb-threatening ischemia nd the overall impact of 
revascularization in these patients 26 do not apply to 
this report. 
Overall satisfactory results were reported by 82% 
of our patients, with age younger than 70 years and 
definitive hemodynamic correction being indepen- 
dent correlates of patient satisfaction; patients treat- 
able with inflow procedures were also more likely to 
report satisfactory results, although two thirds of 
patients treated with infrainguinal grafts were also 
satisfied. We believe the potential eg and wound 
morbidity associated with infrainguinal revasculariza- 
tion may explain these findings. Gibbons et al.,26 in 
assessing functional status, well-being, and symptom 
relief of patients after infrainguinal revascularization 
for severe peripheral vascular disease, reported that in 
particular leg swelling often persisted beyond 6 
months after operation. 
If  satisfactory s mptom relief is to be achieved, the 
approach to the patient with multisegment occlusive 
disease must be individualized. The surgeon will need 
convincing data as to the principal evel of  hemody- 
namic compromise. Our data suggests that near 
normalization of postoperative ABI should be antici- 
pated to ensure patient satisfaction. Patients in whom 
this definitive hemodynamic orrection occurred 
were six times more likely to report a satisfactory 
outcome when compared with patients with lesser 
degrees of hemodynamic correction. This finding 
implies that proximal operation in the presence of 
extensive uncorrected distal disease will not produce 
satisfactory esults. 
We conclude that surgical bypass for claudication 
will produce optimal results when restricted to 
younger patients in whom near normalization ofpost- 
operative ABI can be anticipated. Our data also indi- 
cate that the threshold for intervention for claudica- 
tion in diabetic patients hould be elevated because of 
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Tab le  V.  Life table analysis o f  secondary  graft patency 
Interval No. at No. lost to Interval patency Cumulative Standard error 
(mo) risk 'No. withdrawn follow-#p No. failed (%) patency (%) (%) 
Inflow 
0-6 64 5 0 1 98.4 100.0 0.0 
6-12 58 2 0 0 100.0 98.4 1.6 
12-18 56 9 0 0 100.0 98.4 1.6 
18-24 47 4 0 0 98.4 98.4 1.6 
24-30 43 3 0 0 100.0 98.4 1.6 
30-36 40 6 0 0 100.0 98.4 1.6 
36-42 34 2 0 0 100.0 98.4 1.6 
42-48 32 3 0 0 100.0 98.4 1.6 
48-54 29 4 0 0 100.0 98.4 1.6 
54-60 25 4 0 0 100.0 98.4 1.6 
60-66 21 5 0 0 100.0 98.4 1.6 
66-72 16 6 0 0 100.0 98.4 1.6 
72-78 10 2 0 0 100.0 98.4 1.6 
Outflow 
0-6 40 5 0 3 92.0 100.0 1.4 
6-12 32 6 0 0 100.0 92.0 4.4 
12-18 26 4 0 0 100.0 92.0 4.4 
18-24 22 3 0 0 100.0 92.0 4.4 
24-30 19 1 0 0 100.0 92.0 4.4 
30-36 18 3 0 0 100.0 92.0 4.4 
36-42 15 3 0 0 100.0 92.0 4.4 
42-48 12 1 0 0 100.0 92.0 4.4 
48-54 11 3 0 0 100.0 92.0 4.4 
54-60 8 0 0 0 100.0 92.0 4.4 
60-66 8 1 0 0 100.0 92.0 4.4 
66-72 7 1 0 0 100.0 92.0 4.4 
72-78 6 3 0 0 100.0 92.0 4.4 
Tab le  V I .  Factors associated wi th  pat ients '  assessment o f  a satisfactory outcome in 97 surgically 
t reated patients wi th  c laudicat ion 
Satisfaction 
Variable No (N = 17) (%) Yes (N = 80) (%) p 
Age >70 yr 9 (53) 13 (17) 0.001 
Diabetes 2 (12) 12 (15) 0.73 
Status after CABG 8 (47) 17 (22) 0.03 
NormalizationABI 9 (33) 72 (90) 0.002 
Imp?ovementABI 14 (82) 64 (80) 0.824 
Type of operation 
Outflow 10 (59) 27 (34) 0.05 
Inflow 7 (41) 53 (66) 0.05 
Late graft failure 4 (23) 8 (10) 0.136 
their  demonst ra ted  infer ior late survival. A l though 
these data have the l imitat ions o f  retrospect ive r view, 
they may be useful in the design o f  prospect ive trials in 
pat ients wi th claudication. In  an era when lifestyle- 
mod i fy ing  intervent ions  will come under  increasing 
scrutiny, such trials will be requ i red  to establish the 
efficacy and wor th  o f  in tervent ions  for claudication. 
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Appendix I. Questionnaire administered to pa- 
tients treated surgically for intermittent claudication 
1. Was your walking ability improved after the opera- 
tion compared with before? 
2. Is your walking ability improved now compared 
with before your surgery? 
3. Was the discomfort of surgery and hospitalization 
time worth it to you? 
4. Would you recommend surgery to a friend with 
the same problem? 
5. Overall are you satisfied with the result of your 
surgery? 
